COMMUNIQUÉS West-GlobeNewswire

Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole

18/04/2018 - 07:16

Basel, Switzerland, April 18, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its license partner Asahi Kasei Pharma Corporation ("Asahi Kasei Pharma") has started enrollment in a clinical phase 3 [...]

Curetis: Novel Products and Study Data to be Presented at ECCMID 2018

18/04/2018 - 07:02

Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 Introduction of Unyvero UTI Application Cartridge Update on A30 RQ Analyzer to be provided MGI/Curetis NGS Solution for Molecular Microbiology to be [...]

GUERBET : 1st quarter 2018 revenue

18/04/2018 - 07:01

€196.5 million at constant exchange rates: -3.2% Villepinte, April 18, 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €183.2 million [...]

GUERBET : Chiffre d'affaires 1er trimestre 2018

18/04/2018 - 07:01

196,5 M€ à taux de change constant : -3,2% Villepinte, le 18 avril 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie un chiffre d'affaires de [...]

GUERBET : GEAR 2023 strategic plan

18/04/2018 - 07:01

Villepinte, April 18, 2018 - Guerbet ( the "Company "), a global specialist in contrast agents and solutions for medical imaging, has released today its GEAR 2023 strategic plan. About Guerbet Guerbet is a leading [...]

GUERBET : Plan stratégique GEAR 2023

18/04/2018 - 07:01

Villepinte, 18 avril 2018 - Guerbet (la « Société ») , spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie aujourd'hui son plan stratégique GEAR 2023. A propos de Guerbet Guerbet [...]

DiaMedica Issues Stock Option Grants

18/04/2018 - 03:00

MINNEAPOLIS, April 17, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the " Company ") (TSX-V: DMA ) (OTCQB:DMCAF), today announced the issuance of 2,551,000 stock options to various officers and directors of the [...]

ALK’s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet

18/04/2018 - 03:00

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that its partner for Japan, Torii Pharmaceutical Co., Ltd., has agreed a price with authorities and secured a listing on Japan’s National Health Insurance [...]

Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock

18/04/2018 - 00:26

HOUSTON, April 17, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and [...]

Maple Leaf Begins Constructing the Building Structure on its Telkwa, British Columbia Facility

18/04/2018 - 00:09

CALGARY, Alberta, April 17, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSXV:MGW) (OTCQB:MGWFF) is pleased to announce that it has received a progress report from the [...]

National Research Corporation Announces Consummation of Class B Common Stock Recapitalization

17/04/2018 - 23:00

LINCOLN, Neb., April 17, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced that its shareholders approved the December 2017 announced recapitalization plan pursuant [...]

Encinitas Dentist Urges Screenings in Light of Oral Cancer Awareness Month

17/04/2018 - 23:00

With April marking the arrival of National Oral Cancer Awareness Month, Dr. Cathy Santone of Encinitas Cosmetic Dentistry is encouraging patients to incorporate a screening into their routine dental visit and donating [...]

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%

17/04/2018 - 22:35

BUENA, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

Marrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock

17/04/2018 - 22:30

DAVIS, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) or ("the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and [...]

Retrophin to Report First Quarter 2018 Financial Results

17/04/2018 - 22:30

SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced it will report first quarter 2018 financial results on Tuesday, May 1, 2018 after the close of the U.S. financial markets. [...]

EyeGate Announces Completion of $11.25 Million Public Offering

17/04/2018 - 22:30

WALTHAM, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (Nasdaq: EYEG ) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products [...]

Globus Medical Schedules First Quarter 2018 Earnings Release and Conference Call

17/04/2018 - 22:24

AUDUBON, Penn., April 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after [...]

Medigus and HC Marbella International Hospital Announce First MUSE™ Procedure for GERD Treatment in Spain

17/04/2018 - 22:05

-Leading gastroenterologist reports successful procedure with comprehensive endoscopic device- OMER, Israel, and MARBELLA, Spain, April 17, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical [...]

Syneos Health Schedules First Quarter 2018 Earnings Call for Wednesday, May 9, 2018

17/04/2018 - 22:05

RALEIGH, N.C., April 17, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial Organization), will [...]